This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baraniak, A.
Right arrow Articles by Gniadkowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baraniak, A.
Right arrow Articles by Gniadkowski, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2002, p. 1095-1097, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1095-1097.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Two Different Extended-Spectrum ß-Lactamases (ESBLs) in One of the First ESBL-Producing Salmonella Isolates in Poland

Anna Baraniak, Ewa Sadowy, Waleria Hryniewicz, and Marek Gniadkowski*

Sera & Vaccines Central Research Laboratory, Chelmska 30/34, 00-725 Warsaw, Poland

Received 31 October 2001/ Returned for modification 24 December 2001/ Accepted 17 January 2002


arrow
ABSTRACT
 
Two extended-spectrum ß-lactamase (ESBL)-producing salmonella isolates, Salmonella enterica serovar Enteritidis and Salmonella enterica serovar Typhimurium, were analyzed. Both isolates produced the CTX-M-3 ESBL; however, their blaCTX-M-3 genes were located on different plasmids. The serovar Typhimurium isolate also expressed another ESBL, SHV-2a, and probably the two ESBL genes had been acquired independently by the strain.


arrow
TEXT
 
Various types of extended-spectrum ß-lactamases (ESBLs) constitute one of the major mechanisms of resistance of gram-negative bacteria to oxyimino-ß-lactam antibiotics (10, 13, 17). In general they are most frequently identified in Klebsiella pneumoniae and Escherichia coli; however, more and more papers in recent years have documented their growing incidence in other organisms of the family Enterobacteriaceae, including Salmonella spp. (10, 17). Sporadic infections or nosocomial outbreaks caused by ESBL-producing salmonellae have been reported in numerous countries of Latin America, Africa, Asia, and Europe (4, 8, 18, 19). Salmonellae have been found to express a wide variety of ESBL types, including TEM, SHV, PER, and CTX-M enzymes (10, 13, 18). The situation is of particular concern because it demonstrates the danger of ESBL spread among pathogens circulating in livestock and the community (17).

Although frequently found in many enterobacterial species, ESBL had not been reported in Salmonella spp. in Poland until 1999. The two cefotaxime-resistant isolates analyzed in this work belong to the first ESBL-producing salmonellae identified in the country. They were recovered in 1999 and 2000 in two regional hospitals located in geographically distant cities (Table 1). Both strains were cultured from the stools of patients with diarrhea. Biochemical identification of the isolates was performed with the ATB ID32E test (bioMérieux sa, Marcy l'Etoile, France). Serogroups and serotypes with respect to somatic (O) and flagellar (H) antigens were determined in the Public Health Sanitary-Epidemiological Station in Warsaw. Isolate 9197 from Grajewo was classified as Salmonella enterica serovar Typhimurium, and isolate 33/01 from Koszalin was identified as Salmonella enterica serovar Enteritidis. ESBL production was detected by the double disk synergy test (12).


View this table:
[in this window]
[in a new window]
  		TABLE 1. The salmonella isolates: date and place of isolation, ß-lactamase profiles, ß-lactamases expressed by transconjugants, cefotaxime-hydrolyzing activity assigned by the bioassay, ESBL sequences deduced from gene sequences, and plasmid fingerprints

The two salmonella isolates were subjected to the cefotaxime resistance transfer experiment as described previously (3), with E. coli A15, resistant to nalidixic acid, as the recipient strain. Transconjugants were selected on MacConkey agar (Oxoid, Basingstoke, United Kingdom) supplemented with cefotaxime (2 µg/ml; Polfa Tarchomin, Warsaw, Poland) and nalidixic acid (64 µg/ml; Sigma Chemical Company, St. Louis, Mo.). Both isolates produced transconjugants with an efficiency of around 10-4 per donor cell. MICs of various antibiotics were evaluated for the isolates and the transconjugants by the agar dilution method according to the NCCLS guidelines (14). Antimicrobial standards were supplied by the corresponding manufacturers. Both clinical isolates and their transconjugants revealed MIC patterns that are typical for ESBL-producing strains (13) (Table 2). They were characterized by raised MICs of a variety of ß-lactams, except for cefoxitin and imipenem, and ß-lactamase inhibitors reduced effectively MICs of ß-lactams in all combinations tested. Cefotaxime MICs were significantly higher than those of ceftazidime. Apart from ß-lactams the clinical isolates were also resistant to aminoglycosides and cotrimoxazole, and resistance to these drugs was cotransferred with ß-lactam resistance to the transconjugants.


View this table:
[in this window]
[in a new window]
  		TABLE 2. MICs of various antimicrobial agents obtained for the clinical isolates and their transconjugants

ß-Lactamases of the clinical isolates and their transconjugants were visualized by isoelectric focusing (IEF), and their cefotaxime-hydrolyzing activity was detected by the bioassay approach. IEF and the bioassay were performed as described by Bauernfeind et al. (3), with the use of a Model 111 Mini Cell (Bio-Rad, Hercules, Calif.) for IEF. The concentration of cefotaxime in the bioassay was 2 µg/ml. Results of the analyses are shown in Table 1. Both isolates produced ß-lactamases with isoelectric points (pIs) of 8.4 and 5.4, and these two enzymes were also found in extracts of the transconjugants. The serovar Typhimurium isolate, 9197, but not its transconjugant, expressed an additional ß-lactamase with a pI of 7.6. Only enzymes with pIs of 8.4 and 7.6 demonstrated the cefotaxime-hydrolyzing activity under the conditions used in the bioassay (the ß-lactamase with a pI of 5.4 was probably TEM-1).

Genes coding for the cefotaxime-hydrolyzing ß-lactamases were detected by PCR in DNA of the clinical isolates. Both isolates were tested for the presence of blaCTX-M genes (supposed to encode the pI 8.4 enzymes), and DNA of serovar Typhimurium 9197 was also checked by PCR specific for a blaSHV gene (likely coding for the ß-lactamase with a pI of 7.6). PCRs were run as reported previously (6, 11). Amplicons of the expected size of around 1 kb were obtained in all three cases and subjected to sequencing using an ABI PRISM 310 sequencer (PE Biosystems, Foster City, Calif.). Sequencing was performed as previously described (1, 6, 11). The results are shown in Table 1. Coding regions of the two blaCTX-M genes were identical to that of the blaCTX-M-3 gene (11), which indicated that the ß-lactamase with a pI of 8.4 was CTX-M-3. The blaSHV gene coding region was of the same nucleotide sequence as in the originally reported blaSHV-2a gene (16), and this revealed that the ESBL with a pI of 7.6 was SHV-2a.

Plasmid DNA was purified from the transconjugants with the use of the QIAGEN Plasmid Midi Kit (QIAGEN, Hilden, Germany) and subjected to the fingerprinting analysis along with all the variants of blaCTX-M-3 gene-carrying plasmids that had been identified before in Enterobacteriaceae isolates in Poland (1). The PstI restrictase (MBI Fermentas, Vilnius, Lithuania) fingerprinting was performed as reported previously (11). Both transconjugants contained large plasmids (of around 90 to 110 kb) that produced different fingerprints (Table 1 and Fig. 1). The plasmid specific for serovar Enteritidis 33/01 had a fingerprint identical to that of the widely spread blaCTX-M-3 gene-carrying plasmid in Poland (variant A1) (1), whereas the molecule present in serovar Typhimurium 9197 demonstrated a unique PstI restriction pattern.



View larger version (63K):
[in this window]
[in a new window]
  		FIG. 1. Plasmid fingerprinting analysis performed with the use of the PstI restriction enzyme (MBI Fermentas). Lanes: 1, GeneRuler 100-bp DNA Ladder Plus (MBI Fermentas); 2, Serovar Enteritidis 33/01, pattern A1; 3, Serovar Typhimurium 9197, pattern E; 4, C. freundii 2526/96, pattern A1 (1, 11, 15); 5, E. coli 279, pattern B (15); 6, E. coli SU 8350, pattern C (1); 7, E. coli BB 1775, pattern D (1).

With the two multiresistant serovar Typhimurium and serovar Enteritidis isolates analyzed here and an S. enterica serovar Mbandaka isolate reported elsewhere (21), Poland has joined the group of countries in which ESBL-producing salmonellae have been described. Both strains produced the CTX-M-3 enzyme, identified originally in 1996 in Citrobacter freundii isolates from a hospital in Warsaw (11). CTX-M ß-lactamases have been relatively frequently found in ESBL-producing salmonellae, including CTX-M-2 in Argentina (2), CTX-M-4 in Russia (9), CTX-M-5 in Latvia (4), CTX-M-6 and -7 in Greece (8), and probably CTX-M-9 in Spain (19). The CTX-M-4 and -5-producing serovar Typhimurium strains caused clonal outbreaks in hospitals in St. Petersburg and Riga, respectively (4, 7, 22), and serovar Typhimurium strains related to those from St. Petersburg have been also observed in Hungary and Greece (22).

The CTX-M-3 ß-lactamase is widely spread in Poland, having been identified in numerous strains of seven Enterobacteriaceae species in 16 medical centers throughout the country (1, 11, 15). The isolation of CTX-M-3-producing salmonella strains in hospitals in Grajewo and Koszalin has extended the list by two more institutions. The blaCTX-M-3 gene-carrying plasmids of both isolates demonstrated a high transmission potential; moreover, one of these had been observed before in nine hospitals, which suggests its nosocomial origin (1, 11, 15). These data support the hypothesis that plasmid dissemination has been the major mechanism of the CTX-M-3 spread in Poland (1, 15). What is noteworthy is that these plasmids also contained a gene coding for another ß-lactamase (likely TEM-1) and genes responsible for resistance to aminoglycosides and cotrimoxazole. One of the salmonella isolates, apart from CTX-M-3, also produced another ESBL variant, SHV-2a, which had previously never been identified in Poland. Genes coding for the two ESBLs have probably been acquired independently by the strain, as they were located on separate DNA replicons. Such double-ESBL-producer strains, although occasionally reported (1, 5, 20), are rare, and to our knowledge they have not been observed in salmonella to date.


arrow
ACKNOWLEDGMENTS
 
We thank Krystyna Nowak for serotyping and Anna Klim, Boenna Ruszel, and Tadeusz Gadomski for collecting the isolates. We also thank Jolanta Krzyszto-Russjan and Kent Holding for helpful discussions and Agnieszka Mrówka for her excellent technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Sera & Vaccines Central Research Laboratory, ul. Chelmska 30/34, 00-725 Warsaw, Poland. Phone: (48) 22-851 46 70. Fax: (48) 22-841 29 49. E-mail: gniadkow{at}urania.il.waw.pl. Back


arrow
REFERENCES
 
    1
  1. Baraniak, A., J. Fiett, A. Sulikowska, W. Hryniewicz, and M. Gniadkowski. 2002. A countrywide spread of CTX-M-3 extended-spectrum ß-lactamase (ESBL)-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob. Agents Chemother. 46:151-159.[Abstract/Free Full Text]
    2. 2
  2. Bauernfeind, A., J. M. Casellas, M. Goldberg, M. Holley, R. Jungwirth, P. Mangold, T. Röhnisch, S. Schweighart, and R. Wilhelm. 1992. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20:158-163.[CrossRef][Medline]
    3. 3
  3. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.[CrossRef][Medline]
    4. 4
  4. Bradford, P. A., Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch. 1998. CTX-M-5, a novel cefotaxime-hydrolyzing ß-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980-1984.[Abstract/Free Full Text]
    5. 5
  5. Essack, S. Y., L. C. M. Hall, D. G. Pillay, M. L. McFyden, and D. M. Livermore. 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum ß-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 45:88-95.[Abstract/Free Full Text]
    6. 6
  6. Fiett, J., A. Palucha, B. Miczyska, M. Stankiewicz, H. Przondo-Mordarska, W. Hryniewicz, and M. Gniadkowski. 2000. A novel complex mutant ß-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum ß-lactamase-producing klebsiellae. Antimicrob. Agents Chemother. 44:1499-1505.[Abstract/Free Full Text]
    7. 7
  7. Gazouli, M., S. V. Sidorenko, E. Tzelepi, N. S. Kozlova, D. P. Gladin, and L. S. Tzouvelekis. 1998. A plasmid-mediated ß-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia. J. Antimicrob. Chemother. 41:119-121.[Abstract/Free Full Text]
    8. 8
  8. Gazouli, M., E. Tzelepi, A. Markogiannakis, N. J. Legakis, and L. S. Tzouvelekis. 1998. Two novel plasmid-mediated cefotaxime-hydrolyzing ß-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium. FEMS Microbiol. Lett. 165:289-293.[Medline]
    9. 9
  9. Gazouli, M., E. Tzelepi, S. V. Sidorenko, and L. S. Tzouvelekis. 1998. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A ß-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob. Agents Chemother. 42:1259-1262.[Abstract/Free Full Text]
    10. 10
  10. Gniadkowski, M. 2001. Evolution and epidemiology of extended-spectrum ß-lactamases (ESBLs) and ESBL-producing microorganisms. Clin. Microbiol. Infect. 7:597-608.[CrossRef][Medline]
    11. 11
  11. Gniadkowski, M., I. Schneider, A. Palucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing ß-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.[Abstract/Free Full Text]
    12. 12
  12. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1998. Extended broad-spectrum ß-lactamases conferring transferable resistance to newer ß-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
    13. 13
  13. Livermore, D. M. 1995. ß-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.[Abstract]
    14. 14
  14. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-fifth edition, M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    15. 15
  15. Palucha, A., B. Mikiewicz, W. Hryniewicz, and M. Gniadkowski. 1999. Concurrent outbreaks of extended-spectrum ß-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J. Antimicrob. Chemother. 44:489-499.[Abstract/Free Full Text]
    16. 16
  16. Podbielski, A., J. Schonling, B. Melzer, K. Warnatz, and H. G. Leusch. 1991. Molecular characterization of a new plasmid-encoded SHV-type ß-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J. Gen. Microbiol. 137:569-578.[Abstract/Free Full Text]
    17. 17
  17. Rahal, J. J. 2000. Extended-spectrum ß-lactamases: how big is the problem? Clin. Microbiol. Infect. 6(Suppl. 2):2-6.[CrossRef]
    18. 18
  18. Shannon, K., and G. French, G. 1998. Multiple-antibiotic-resistant salmonella. Lancet 352:490-491.[Medline]
    19. 19
  19. Simarro, E., F. Navarro, J. Ruiz, E. Miró, J. Gómez, and B. Mirelis. 2000. Salmonella enterica serovar Virchow with CTX-M-like ß-lactamase in Spain. J. Clin. Microbiol. 38:4676-4678.[Abstract/Free Full Text]
    20. 20
  20. Soilleux, M. J., A. M. Morand, G. J. Arlet, M. R. Scavizzi, and R. Labia. 1996. Survey of Klebsiella pneumoniae producing extended-spectrum ß-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrob. Agents Chemother. 40:1027-1029.[Abstract]
    21. 21
  21. Szych, J., A. Cielik, J. Paciorek, and S. Kaluewski. 2001. Antibiotic resistance in Salmonella enterica subsp. enterica strains isolated in Poland from 1998 to 1999. Int. J. Antimicrob. Agents 18:37-42.[CrossRef][Medline]
    22. 22
  22. Tassios, P. T., M. Gazouli, E. Tzelepi, H. Milch, N. Kozlova, S. Sidorenko, N. J. Legakis, and L. S. Tzouvelekis. 1999. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J. Clin. Microbiol. 37:3774-3777.[Abstract/Free Full Text]

Journal of Clinical Microbiology, March 2002, p. 1095-1097, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1095-1097.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Golebiewski, M., Kern-Zdanowicz, I., Zienkiewicz, M., Adamczyk, M., Zylinska, J., Baraniak, A., Gniadkowski, M., Bardowski, J., Ceglowski, P. (2007). Complete Nucleotide Sequence of the pCTX-M3 Plasmid and Its Involvement in Spread of the Extended-Spectrum {beta}-Lactamase Gene blaCTX-M-3. Antimicrob. Agents Chemother. 51: 3789-3795 [Abstract] [Full Text]  
  • Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., Poirel, L., Woodford, N. (2007). CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165-174 [Abstract] [Full Text]  
  • Morris, D., Whelan, M., Corbett-Feeney, G., Cormican, M., Hawkey, P., Li, X., Doran, G. (2006). First Report of Extended-Spectrum-{beta}-Lactamase-Producing Salmonella enterica Isolates in Ireland.. Antimicrob. Agents Chemother. 50: 1608-1609 [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Hasman, H., Mevius, D., Veldman, K., Olesen, I., Aarestrup, F. M. (2005). {beta}-Lactamases among extended-spectrum {beta}-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 56: 115-121 [Abstract] [Full Text]  
  • Baraniak, A., Fiett, J., Mrowka, A., Walory, J., Hryniewicz, W., Gniadkowski, M. (2005). Evolution of TEM-Type Extended-Spectrum {beta}-Lactamases in Clinical Enterobacteriaceae Strains in Poland. Antimicrob. Agents Chemother. 49: 1872-1880 [Abstract] [Full Text]  
  • Ishii, Y., Kimura, S., Alba, J., Shiroto, K., Otsuka, M., Hashizume, N., Tamura, K., Yamaguchi, K. (2005). Extended-Spectrum {beta}-Lactamase-Producing Shiga Toxin Gene (stx1)-Positive Escherichia coli O26:H11: a New Concern. J. Clin. Microbiol. 43: 1072-1075 [Abstract] [Full Text]  
  • Kruger, T., Szabo, D., Keddy, K. H., Deeley, K., Marsh, J. W., Hujer, A. M., Bonomo, R. A., Paterson, D. L. (2004). Infections with Nontyphoidal Salmonella Species Producing TEM-63 or a Novel TEM Enzyme, TEM-131, in South Africa. Antimicrob. Agents Chemother. 48: 4263-4270 [Abstract] [Full Text]  
  • Munday, C. J., Whitehead, G. M., Todd, N. J., Campbell, M., Hawkey, P. M. (2004). Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum {beta}-lactamases in York, UK. J Antimicrob Chemother 54: 628-633 [Abstract] [Full Text]  
  • Edelstein, M., Pimkin, M., Dmitrachenko, T., Semenov, V., Kozlova, N., Gladin, D., Baraniak, A., Stratchounski, L. (2004). Multiple Outbreaks of Nosocomial Salmonellosis in Russia and Belarus Caused by a Single Clone of Salmonella enterica Serovar Typhimurium Producing an Extended-Spectrum {beta}-Lactamase. Antimicrob. Agents Chemother. 48: 2808-2815 [Abstract] [Full Text]  
  • Naumiuk, L., Baraniak, A., Gniadkowski, M., Krawczyk, B., Rybak, B., Sadowy, E., Samet, A., Kur, J. (2004). Molecular Epidemiology of Serratia marcescens in Two Hospitals in Danzig, Poland, over a 5-Year Period. J. Clin. Microbiol. 42: 3108-3116 [Abstract] [Full Text]  
  • Chiu, C.-H., Su, L.-H., Chu, C. (2004). Salmonella enterica Serotype Choleraesuis: Epidemiology, Pathogenesis, Clinical Disease, and Treatment. Clin. Microbiol. Rev. 17: 311-322 [Abstract] [Full Text]  
  • Bonnet, R. (2004). Growing Group of Extended-Spectrum {beta}-Lactamases: the CTX-M Enzymes. Antimicrob. Agents Chemother. 48: 1-14 [Full Text]  
  • Makanera, A., Arlet, G., Gautier, V., Manai, M. (2003). Molecular Epidemiology and Characterization of Plasmid-Encoded {beta}-Lactamases Produced by Tunisian Clinical Isolates of Salmonella enterica Serotype Mbandaka Resistant to Broad-Spectrum Cephalosporins. J. Clin. Microbiol. 41: 2940-2945 [Abstract] [Full Text]  
  • Su, L.-H., Chiu, C.-H., Chu, C., Wang, M.-H., Chia, J.-H., Wu, T.-L. (2003). In Vivo Acquisition of Ceftriaxone Resistance in Salmonella enterica Serotype Anatum. Antimicrob. Agents Chemother. 47: 563-567 [Abstract] [Full Text]  
  • Mulvey, M. R., Soule, G., Boyd, D., Demczuk, W., Ahmed, R. (2003). Characterization of the First Extended-Spectrum Beta-Lactamase-Producing Salmonella Isolate Identified in Canada. J. Clin. Microbiol. 41: 460-462 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baraniak, A.
Right arrow Articles by Gniadkowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baraniak, A.
Right arrow Articles by Gniadkowski, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»